How Much Does Ketamine Therapy Cost? A Complete 2025 Pricing Guide

How much does ketamine therapy cost? Prices range from about $100 to $400 per month for compounded oral or sublingual ketamine prescribed through telehealth, up to $400 to $800 per session for in-clinic IV infusions, with a typical six-session initial series running $2,400 to $4,800 out of pocket. Spravato (esketamine), the only FDA-approved ketamine-based depression treatment, lists for $600 to $900 per session but often costs $0 to $200 per session for patients with commercial insurance and an approved prior authorization.

The final price depends on the administration method, the clinical setting, geographic location, how often treatment is needed, and whether insurance covers any part of it. This guide breaks down real cost ranges for every major ketamine therapy format, explains what drives insurance coverage decisions, and lists the questions worth asking before you commit to a provider.

IV Ketamine Infusion Costs

Intravenous (IV) ketamine infusion is the most studied ketamine delivery method for psychiatric use and the service most dedicated ketamine clinics build their practice around. Because IV ketamine for depression and anxiety is an off-label use, meaning the FDA has not approved ketamine itself for these conditions, it is almost always an out-of-pocket expense.

Individual IV sessions typically cost $400 to $800. That price usually covers the pre-treatment assessment, the ketamine medication, IV supplies and pump use, roughly 40 minutes of clinical monitoring during the infusion, and a 30 to 60 minute recovery period before discharge. Clinics in major metro areas such as New York, Los Angeles, San Francisco, and Chicago tend to charge toward the top of that range, while clinics in smaller markets and suburbs are often less expensive. Local competition among clinics also affects pricing.

Initial Treatment Series

The standard induction protocol is six infusions over two to three weeks. At typical per-session rates, that works out to $2,400 at the low end, roughly $3,300 at a mid-range rate of $550 per session, and up to $4,800 at the high end. Some clinics discount 10% to 20% off the per-session rate when patients prepay for the full series, so ask about package pricing before booking.

Maintenance Costs

Most patients need ongoing maintenance infusions to hold onto the benefits of the initial series. Maintenance intervals commonly range from every two weeks to every six weeks, and the schedule has a large effect on annual cost.

Including the initial series, most patients spend $6,000 to $15,000 on IV ketamine in the first year, depending on how often maintenance sessions are needed.

Spravato (Esketamine) Costs

Spravato is the brand name for esketamine, a nasal spray manufactured by Janssen Pharmaceuticals and the only ketamine-based medication the FDA has approved for depression, cleared for treatment-resistant depression and for major depressive disorder with suicidal ideation. That FDA approval status is what makes Spravato coverage fundamentally different from off-label IV, IM, or compounded ketamine: insurers evaluate it like any other approved prescription drug rather than an experimental therapy. Spravato is chemically distinct from generic racemic ketamine used in IV and oral formulations; see our comparison of racemic ketamine versus esketamine for the clinical differences.

List Price

The manufacturer's list price for Spravato runs $600 to $900 per session depending on the dose (56 mg or 84 mg). Clinics also charge a facility fee, typically $50 to $300 per session, to cover the required two-hour post-dose monitoring period.

With Insurance

For patients whose plan covers Spravato, out-of-pocket costs drop substantially. Copays commonly range from $0 to $200 per session once prior authorization is approved, though costs can be higher before the annual deductible is met. Janssen's patient savings program can lower costs to as little as $10 per session for eligible commercially insured patients. Insured patients typically spend $2,000 to $6,000 per year on Spravato, depending on their copay structure, deductible, and session frequency.

Without Insurance

Uninsured Spravato treatment is the most expensive option in this guide. Combining the $600 to $900 medication cost with the $50 to $300 facility fee puts each session at roughly $650 to $1,200, or $15,000 to $30,000 or more per year at typical maintenance frequencies.

Getting Insurance to Approve Spravato

Most insurers require documentation that a patient has treatment-resistant depression, generally defined as an inadequate response to at least two adequate antidepressant trials, before approving Spravato. The prescribing provider submits clinical documentation, the insurer reviews medical necessity, and a peer-to-peer review or appeal may follow an initial denial. Approval can take anywhere from a few days to several weeks, and some clinics employ staff specifically to manage prior authorizations. For more detail on how coverage decisions get made, see our guide to ketamine insurance coverage.

Oral and Sublingual Ketamine Costs

Compounded oral and sublingual ketamine, usually prescribed as lozenges or tablets, is the least expensive entry point into ketamine therapy. Psychiatrists and other qualified prescribers offer it through in-person visits or telehealth platforms.

Telehealth Program Pricing

At-home telehealth programs typically bill through a monthly subscription. Basic programs, which include the medication, provider consultations, and monitoring, run $150 to $250 per month. Premium programs that add more frequent check-ins, integration coaching, or psychotherapy support run $250 to $400 per month. Some providers instead charge per consultation, $100 to $250, plus a separate compounded medication cost of $50 to $150 per month.

In-Person Prescribing

Getting an oral or sublingual prescription from a local psychiatrist or pain management specialist follows a more traditional fee structure: an initial evaluation of $200 to $500, follow-up visits of $100 to $300 each, and compounded medication from a specialty pharmacy at $50 to $200 per month. Annual costs commonly land between $1,500 and $5,000 depending on visit frequency and pharmacy pricing.

Why It Costs Less

Oral and sublingual ketamine avoids the clinic facility fees that drive up IV and Spravato pricing, the medication itself is inexpensive to compound, telehealth delivery cuts overhead compared to running an infusion suite, and visit frequency is usually lower once a patient reaches a stable dose.

Intramuscular (IM) Injection Costs

Intramuscular ketamine injection sits between IV infusion and oral formulations on both cost and clinical protocol. Sessions typically run $250 to $600, administered in a clinical setting, though some providers train patients for supervised self-administration. Annual costs generally range from $3,000 to $9,000 depending on frequency. IM injection is offered less widely than IV infusion or oral ketamine, so availability may be limited depending on where you live.

Hidden and Additional Costs

Direct treatment fees are not the full picture. A few recurring add-on costs are easy to underestimate.

Transportation. IV, Spravato, and IM sessions all require a companion to drive the patient home. Rideshare or taxi fare can add $20 to $60 per round trip, or $240 to $720 per year for monthly treatment.

Time away from work. Each in-clinic visit takes roughly two to three hours, not counting travel. Patients without a flexible schedule may need to use paid time off or absorb lost wages.

Complementary therapy. Many providers recommend pairing ketamine with psychotherapy, including cognitive behavioral therapy or ketamine-assisted psychotherapy (KAP). Additional sessions typically cost $100 to $250 and may not be covered by insurance separately from the ketamine treatment itself.

Lab work and medical clearance. Some providers require baseline blood pressure monitoring, liver function tests, or cardiac evaluation before starting treatment and periodically afterward. These can run $50 to $500 depending on the tests ordered and diagnostic coverage.

Insurance Coverage: The Current Landscape

Coverage depends heavily on which ketamine format you use. According to the FDA, Spravato is approved specifically for treatment-resistant depression and for major depressive disorder with suicidal ideation, and most commercial insurance plans and Medicare cover it for those indications after prior authorization; Medicaid coverage varies by state. Off-label IV ketamine for psychiatric conditions is rarely covered, though pain-related indications have a stronger evidence base and are occasionally reimbursed. Compounded oral and sublingual ketamine, along with the telehealth consultation fees that come with it, is almost always out of pocket.

Ketamine therapy expenses, including off-label uses, are generally eligible for payment through Health Savings Account (HSA) and Flexible Spending Account (FSA) funds because they qualify as medical expenses prescribed by a licensed provider. Confirm eligibility with your specific plan administrator before assuming a particular expense qualifies.

Total medical expenses, including ketamine therapy, may also be deductible on federal tax returns to the extent they exceed 7.5% of adjusted gross income, according to IRS Publication 502.

Is Ketamine Therapy Worth the Cost?

The value of ketamine therapy depends on individual circumstances, but a few factors matter most for prospective patients. According to the National Institute of Mental Health (NIMH), major depressive disorder is one of the most common mental health conditions in the United States, and a subset of patients do not respond adequately to standard antidepressant medications, a pattern often described as treatment-resistant depression. For those patients, the ongoing cost of ineffective treatment, lost productivity, and reduced quality of life can outweigh the cost of ketamine therapy.

Some studies report that ketamine therapy is associated with fewer emergency department visits and psychiatric hospitalizations among patients with severe depression and suicidal ideation, which can offset part of the treatment cost over time. Ketamine is not a cure, however. It is a treatment that typically requires ongoing maintenance, so patients should budget for a recurring expense rather than a one-time purchase. For help finding and vetting a provider, see our guide on how to find a qualified ketamine provider.